Built from the problem
Everest Links has spent 15 years in medtech and worked across hundreds of regulator-facing product registrations. We know how quickly promising launches can become difficult when documentation is fragmented.
Why Everest Nova
We built the regulatory workflow we wished new market entrants had.
Everest Nova brings together practical medtech experience, responsible AI, and human regulatory judgment to make medical-device dossier preparation clearer, faster, and more accessible.
AI for the repetitive work
Everest Nova AI screens structured project context and file inventories, surfaces likely gaps, and helps create focused follow-up requests—so experts can spend more time on judgment and preparation.
People remain accountable
Medtech specialists verify the context, make regulatory judgments, and control dossier delivery. AI does not predict approval or replace authority review.
The goal
Less avoidable friction. More useful healthcare innovation.
Our immediate focus is medical-device dossier preparation for Singapore and Malaysia. By combining experience with AI-assisted readiness work, we aim to reduce avoidable cost and delay while preserving the rigor regulators, clinicians, and patients depend on.
Over time, we hope the same model can support broader medical and pharmaceutical market-access work. Pharmaceutical dossier preparation is not part of the current Everest Nova offering; it is a future-phase ambition.
Learn more about our operating foundation at Everest Links .
Everest Nova prepares documentation packages for client submission and does not guarantee regulatory approval. Approval outcomes depend on the product, evidence quality, data completeness, manufacturing controls, and the independent assessment of the relevant authority.